Moch H - Search Results

1

Interleukin-33 in human gliomas: Expression and prognostic significance.

Gramatzki D, Frei K, Cathomas G, Moch H, Weller M, Mertz KD. Gramatzki D, et al. Among authors: moch h. Oncol Lett. 2016 Jul;12(1):445-452. doi: 10.3892/ol.2016.4626. Epub 2016 May 25. Oncol Lett. 2016. PMID: 27347163 Free PMC article.

2

Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.

Mertz KD, Demichelis F, Kim R, Schraml P, Storz M, Diener PA, Moch H, Rubin MA. Mertz KD, et al. Among authors: moch h. Hum Pathol. 2007 Oct;38(10):1454-62. doi: 10.1016/j.humpath.2007.05.017. Hum Pathol. 2007. PMID: 17889675

3

[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma].

Struckmann K, Mertz K, Staller P, Krek W, Schraml P, Moch H. Struckmann K, et al. Among authors: moch h. Verh Dtsch Ges Pathol. 2005;89:178-83. Verh Dtsch Ges Pathol. 2005. PMID: 18035688 German.

4

Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.

Mertz KD, Demichelis F, Sboner A, Hirsch MS, Dal Cin P, Struckmann K, Storz M, Scherrer S, Schmid DM, Strebel RT, Probst-Hensch NM, Gerstein M, Moch H, Rubin MA. Mertz KD, et al. Among authors: moch h. Int J Cancer. 2008 Aug 1;123(3):569-76. doi: 10.1002/ijc.23565. Int J Cancer. 2008. PMID: 18478571 Free article.

5

Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, Sellers WR, Meyerson M, Linehan WM, Kaelin WG Jr, Signoretti S. Beroukhim R, et al. Among authors: moch h. Cancer Res. 2009 Jun 1;69(11):4674-81. doi: 10.1158/0008-5472.CAN-09-0146. Cancer Res. 2009. PMID: 19470766 Free PMC article.

6

Integrin control of the transforming growth factor-β pathway in glioblastoma.

Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I, Weller M. Roth P, et al. Among authors: moch h. Brain. 2013 Feb;136(Pt 2):564-76. doi: 10.1093/brain/aws351. Epub 2013 Jan 31. Brain. 2013. PMID: 23378223 Free article.

7

αv-Integrin isoform expression in primary human tumors and brain metastases.

Vogetseder A, Thies S, Ingold B, Roth P, Weller M, Schraml P, Goodman SL, Moch H. Vogetseder A, et al. Among authors: moch h. Int J Cancer. 2013 Nov 15;133(10):2362-71. doi: 10.1002/ijc.28267. Epub 2013 Jun 10. Int J Cancer. 2013. PMID: 23661241 Free article.

8

[Clinical autopsy].

Bode PK, Cathomas G, Vogt P, Moch H. Bode PK, et al. Among authors: moch h. Praxis (Bern 1994). 2014 Jan 15;103(2):65-9; quiz 70-1. doi: 10.1024/1661-8157/a001544. Praxis (Bern 1994). 2014. PMID: 24425544 Review. German. No abstract available.

9

Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors.

Rössle M, Cathomas G, Bonapace L, Sachs M, Dehler S, Storz M, Huber G, Moch H, Junt T, Mertz KD. Rössle M, et al. Among authors: moch h. Int J Surg Pathol. 2016 Aug;24(5):394-400. doi: 10.1177/1066896916633856. Epub 2016 Feb 23. Int J Surg Pathol. 2016. PMID: 26912475

10

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.

Weller M, Nabors LB, Gorlia T, Leske H, Rushing E, Bady P, Hicking C, Perry J, Hong YK, Roth P, Wick W, Goodman SL, Hegi ME, Picard M, Moch H, Straub J, Stupp R. Weller M, et al. Among authors: moch h. Oncotarget. 2016 Mar 22;7(12):15018-32. doi: 10.18632/oncotarget.7588. Oncotarget. 2016. PMID: 26918452 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

713 results

Search Page